Roche joins the FDA accelerated approval revamp team, nixing a Tecentriq bladder cancer nod
It looks like another drug has bite the dust for failing to live up to its promise while being accelerated to market. They are all gonna have to look around for a viable alternative. Enuf said.
Roche joins the FDA accelerated approval revamp team, nixing a...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.7¢ |
Change
0.003(6.82%) |
Mkt cap ! $349.6M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.9¢ | 4.5¢ | $963.9K | 20.44M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 1558493 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.7¢ | 1495843 | 7 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |